Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance

  03 March 2024

Antimicrobial resistance (AMR) is a global issue due to improper use of antibiotics. The COVID-19 pandemic has accelerated AMR diffusion, with its clinical and therapeutic features changing. AMR incidence has increased globally, with a varied profile based on germ and microorganism. The increased use of antibiotics and preventive measures during the pandemic led to the spread of resistant microorganisms from low-income countries to the rest of the world. However, there is no clear association between COVID-19 and AMR changes in the post-pandemic period. An integrated, personalized, and regulated use of antibiotics and antimicrobials is needed.

 

Further reading: Antibiotics
Author(s): Lucia Boccabella et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed